Full Text
HTA49 Analysis of Funding Conditions for Orphan Medicines in Spain: Trends in Pricing Reimbursement

Abstract

Authors

M Orchard

Back to Volume 27, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×